Research institutionUnited Statesweill.cornell.edu
Weill Cornell Medicine is the medical school of Cornell University and a leading academic medical center focused on patient care, biomedical research, and the education of future physicians and scientists.
Founded in 1898 as Cornell University Medical College on Manhattan's Upper East Side in New York City, it was renamed in 1998 in recognition of major benefactors Joan and Sanford I. Weill and rebranded Weill Cornell Medicine in 2015. The institution conducts cutting-edge research in areas such as cancer, infectious diseases, cardiovascular conditions, neuroscience, and immunology, translating laboratory discoveries into clinical therapies through numerous clinical trials and collaborations.
Faculty deliver exemplary patient care at affiliated hospitals including NewYork-Presbyterian/Weill Cornell Medical Center and partner with institutions like Memorial Sloan Kettering Cancer Center and The Rockefeller University. It maintains an international presence with Weill Cornell Medicine-Qatar and programs in countries across multiple continents.
As part of Cornell University, the organization ranks among the top U.S. medical schools, emphasizing rigorous education, innovative research funded by sources including the NIH, and global health initiatives while advancing medical knowledge and healthcare delivery.
Also known as Cornell University Medical College, Weill Cornell Medical College, and Weill Cornell College of Medicine.
None yet. When a new project in the record names Weill Cornell Medicine as owner, partner or investor, it shows here.
Oral helicase‑primase inhibitor pritelivir is the first novel‑mechanism FDA‑approved HSV therapy in ~30 years; Phase 3 showed 63% vs 34% healing by Day 28. US availability expected before end of 2026.
